The effects of angiotensin receptor-neprilysin inhibition on major coronary events in patients with acute myocardial infarction: insights from the PARADISE-MI trial
Background: In patients who survive an acute myocardial infarction (AMI), angiotensin-
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
R Mehran, PG Steg, MA Pfeffer, K Jering… - …, 2022 - research.regionh.dk
BACKGROUND: In patients who survive an acute myocardial infarction (AMI), angiotensin-
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.
R Mehran, PG Steg, MA Pfeffer, K Jering, B Claggett… - Circulation, 2022 - europepmc.org
Background In patients who survive an acute myocardial infarction (AMI), angiotensin-
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
The effects of angiotensin receptor-neprilysin inhibition on major coronary events in patients with acute myocardial infarction: insights from the PARADISE-MI trial
R Mehran, PG Steg, MA Pfeffer, K Jering, B Claggett… - Circulation, 2022 - eprints.gla.ac.uk
Background: In patients who survive an acute myocardial infarction (AMI), angiotensin-
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients with Acute Myocardial Infarction: Insights from the PARADISE-MI Trial
R Mehran, PG Steg, MA Pfeffer, K Jering, B Claggett… - Circulation, 2022 - research.rug.nl
Background: In patients who survive an acute myocardial infarction (AMI), angiotensin-
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients with Acute Myocardial Infarction: Insights from the PARADISE-MI Trial
R Mehran, PG Steg, MA Pfeffer, K Jering, B Claggett… - Circulation, 2022 - profiles.wustl.edu
Background: In patients who survive an acute myocardial infarction (AMI), angiotensin-
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
R Mehran, PG Steg, MA Pfeffer, K Jering, B Claggett… - 2022 - pubmed.ncbi.nlm.nih.gov
Background In patients who survive an acute myocardial infarction (AMI), angiotensin-
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …
converting enzyme inhibitors decrease the risk of subsequent major cardiovascular events …